BACKGROUND: Medication nonadherence is a common problem, resulting in significant human and economic cost, which can be a challenge to identify and resolve in practice. Adherence tools have been developed to assist health care providers with managing medication nonadherence; however, there is a need to develop a literature base for using adherence tools effectively.
M edication nonadherence is a common problem, resulting in significant human and economic consequences. [1] [2] [3] [4] [5] [6] Medication adherence rates generally are estimated at around 50% for chronic therapies. 7, 8 Numerous studies have examined the processes and/or effects of adherence interventions, including those provided by pharmacists. 7, [9] [10] [11] [12] [13] [14] Effective interventions generally involve patientprovider interactions in addition to other components such as reminders, adherence aids, and regimen simplification, but long-term improvements tend to be small. 9 Continued innovation and examination of feasibility and practice implications have been recommended. 9 There is evidence that a variety of patient factors contribute to medication nonadherence, including forgetfulness and regimen complexity (unintentional nonadherence), along with negative beliefs about medication benefit, side effects, and cost (intentional nonadherence). 15, 16 Researchers continue to refine and retool adherence questionnaires for multiple purposes, including measuring the effectiveness of adherence interventions, screening for nonadherence, and guiding patient-provider discussions of medication nonadherence. [15] [16] [17] [18] Two recent tools, the Adherence Estimator (AE) and the Drug Adherence Work-up (DRAW) tool, have been designed to help providers identify specific reasons for nonadherence in practice and are freely available for provider use. 17, 18 Practice-based research on the use of these newer tools is limited.
The AE is a 3-item questionnaire designed to identify patients who likely are nonadherent because of beliefs about their medicines. 17 The short length makes it attractive for use in a variety of settings, including community pharmacies and outpatient clinics. While the AE items have demonstrated utility for predicting adherence 19 and have been used in research regarding message framing, 20, 21 there has been little published evidence about using the tool in practice. The online version of yes/no questions and medications assessed). An online survey was used to collect pharmacist and student pharmacist experiences, attitudes, and evaluations of their use of the adherence tools. Participants completed the survey after their sites had completed approximately 20 tool uses. Survey respondents were asked a set of demographic questions, including their gender, pharmacist/resident/student status, years in practice, and degrees for the purpose of describing the sample. Open-ended questions allowed respondents to comment on the benefits and drawbacks of the tools and explain how they typically used the tool (see Appendix, available in online article). Respondents with experience using both tools were asked to comment on which tool they found most useful and whether or not they would continue using either tool. MAXQDA v.11 software was used to code the survey responses at the level of the individual quote. 24, 25 Since many open-ended responses contained multiple ideas, multiple codes could be assigned to each quote or quote segment. Codes were developed iteratively to comprise initial themes, and representative quotes were selected. A member of the research team (Zhang) engaged in a peer audit of the dataset to pose alternative codes and interpretations. 24 Changes were discussed, and final summaries and representative quotes were determined. the AE for health care providers contains recommendations for guiding discussions with patients reporting answers associated with nonadherence. 22 The DRAW tool also has been developed to guide providers in identifying and resolving adherence issues. 18, 23 The DRAW contains 11 items assembled from the adherence literature for identifying a broad range of adherence problems and provides targeted problem-solving recommendations. Published reports using either of these tools in practice are limited. Research is needed to create an evidence base for using adherence tools effectively.
The objectives of this study were to (a) describe the experiences and perspectives of pharmacists and student pharmacists using the AE and DRAW tools in community pharmacies and outpatient clinics and (b) describe medication nonadherence issues identified via use of the AE and DRAW tools.
■■ Methods
This exploratory, practice-based evaluation study used a crossover design with sites randomized, beginning with either the AE or the DRAW tool. We planned that sites would take approximately 6 weeks to use the tool with 20 patients. Sites then would switch tools for use with 20 additional patients. Study sites included 4 independently owned community pharmacies (2 of which were rural) and 6 urban primary care clinics staffed with 1 or more pharmacists from the midwestern United States. Sites were recruited based on their routine provision of cognitive services to patients and prior collaboration with members of the research team. These sites were selected because they had sufficient experience and infrastructure to explore the feasibility of the interventions. Each site had a contact person who participated on an introductory conference call or face-to-face meeting regarding the study protocol. Contact pharmacists were responsible for disseminating the link to online training videos that had been developed for the 2 tools and for involving other pharmacists and student pharmacists in administering the tools. Study versions of the 2 tools were also developed, which included patient demographic information and spaces for the pharmacist to specify up to 4 medications.
Sites were given flexibility to use the tools in a way that was compatible with the needs of each site and suitable to pharmacists and patients, including patient identification and recruitment. This approach was used, since the study objective was not to measure changes in medication adherence, but rather to understand the experiences and evaluations of the pharmacists using these tools in practice. 
■■ Results
On average, the patients described in the adherence tools were 58.2 years of age; 61.7% were female; and they regularly used 8.2 medications ( Table 1 ). The majority of tool users (67%) reported investigating 4 medications, which was the maximum accommodated on each form. The age and gender of the patients targeted were similar for the 2 tools. Both tools focused primarily (around 75%) on the same 4 medication categories (blood pressure, diabetes, central nervous system/psychiatric, and lipid conditions) with a variety of other chronic medications comprising the remainder. According to pharmacist documentation on the tools, the AE required less time to use than the DRAW (6.9 vs. 9.3 minutes, respectively). Also, compared with the AE, community pharmacies delivered a slightly lower proportion of their assigned DRAW tools; student pharmacists, rather than pharmacists, delivered a greater proportion of DRAW tools; and a higher proportion of DRAW tools were administered over the telephone ( Table 1) .
The total number of medications assessed by the submitted AE tools was 691. Based on the published scoring formula (Table 2) , 17 7.7% of medications were considered high risk, and 24.9% of medications were considered medium risk for nonadherence. Since multiple medications were assessed on the same tool, this result translates to more than half of the participating patients (54.5%) having 1 or more medications of at least medium risk, and 18.8% having at least 1 medication considered high risk for nonadherence. The total number of medications assessed by the submitted DRAW tools was 603 (Table 3 ). The majority of tools (82.7%) documented at least 1 yes response to a nonadherence question; 58.2% reported 2 or more; and 34.2% recorded 3 or more yes answers. Considering only the medication-specific DRAW questions and excluding the 3 global DRAW questions, 55.5% of medications had 1 or more yes response to a nonadherence question; 24.5% had 2 or more yes answers; and 8.8% had 3 or more yes answers. Blood pressure medications were the most commonly implicated medication class for both tools (Table 4) .
Respondents submitted 44 surveys during the 2 study periods-20 from community sites and 24 from clinic sites. Based on the DRAW, 21 surveys were submitted, and 23 were based on the AE. Of these, 11 respondents had experience with both tools. Pharmacists completed the majority of surveys (n = 24). The mean years of experience of the community and clinic pharmacists were 5.85 and 13.29, respectively. Female respondents made up 75% of the participants.
For the open-ended survey responses, 2 broad themes emerged: tool benefits and translating tools into practice. These 2 themes illustrated the mixed views of the participants. The "tool benefits" theme (Table 5A ) focused on how pharmacist and student pharmacist participants viewed benefits of the tools in the context of their practice settings. The "translating tools into practice" theme (Table 5B) focused on pharmacist perceptions of their interactions with patients when administering the tools and discussing nonadherence, with a focus on perceived barriers and facilitators of integrating these tools into the workflow. 
Tool Benefits
One of the most salient points for both tools was that using a tool promoted more in-depth discussions about adherence, systematically uncovering the specific reasons for nonadherence that would not have emerged otherwise [coded as: systematic, facilitate discussion]. Student pharmacists in particular found the DRAW tool useful because it provided specific recommendations for resolving adherence issues, whereas more experienced clinic pharmacists reported not needing the guidance [coded as: recommendations]. As 1 pharmacist said about the AE, "I think it's a great starting point for discussions regarding adherence issues. It opened up dialogue and even made people think a little bit differently about the use of their medications when specifically asked." For pharmacists exposed to both tools (n = 11), some gravitated toward the AE because it was "easier to use [in] a more timely fashion," while others preferred the DRAW because it addressed more reasons for nonadherence and was consistent with their existing interview approach.
Translating Tools into Practice
Integrating these tools into workflow was not without challenges and critiques. Some respondents thought the tools took too long to administer, particularly the DRAW, given its additional questions [coded as: time]. Some found the tools were difficult to fit into an already full clinic encounter or to integrate into a wellestablished dispensing process. Also, some respondents found both tools to be at times "repetitive," "tedious," or "awkward" and suggested the format was not how they normally discussed nonadherence within their typical encounters [coded as: repetition and wording]. One person commented about DRAW, "It's hard to have such a structured questionnaire when you have time constraints in your patient care duties."
Twenty-five of the pharmacists and student pharmacists submitting surveys suggested their patient interactions while using these tools contained at least 1 concerning aspect. There were perceptions that patients were not forthcoming or were defensive, or that the subjective nature of belief questions was less valuable than more objective measures [coded as: not receptive, social desirability]. Also, some respondents raised concerns about patient confusion during the encounter and the potential for misinterpretation of the questions, particularly with the AE scaling and the way it switches orientation as to which end of the scale is associated with an adherent (positive) response [coded as: confusion]. As a result, some tool administrators recommended using a simplified, open-ended question format for the AE and DRAW, particularly to facilitate tool use over the telephone [coded as: confusion, open discussion]. As 1 clinic pharmacist said regarding AE, "In practice, I would prefer to allow patients to answer open-ended rather than have them provide numeric answers."
Several pharmacists, student pharmacists, and patients preferred the approach of considering medication nonadherence as a global problem, rather than as a medication-specific issue. This preference seemed to be at least partially related to time and simplicity [coded as: all meds together]. Also, there were 10 comments where tool administrators reported prefacing the tools to patients as something new they were trying or saying that the activity was part of a research study [coded as: prefacing]. A facilitator from the community pharmacy setting was to use the tools in conjunction with dispensing records to target patients where nonadherence appears to be an issue [coded as: refill history].
■■ Discussion
When given flexibility, community and clinic pharmacy sites were largely successful in administering these 2 adherence tools to patients, and with more than half of all patients interviewed, potential reasons for medication nonadherence were uncovered. Many respondents reported positive interactions with receptive patients. Pharmacists and student pharmacists used interaction opportunities such as the medication dispensing process and medication management interventions supported by third-party payers (both in person and by telephone) to administer these tools. Participants from the community setting reported using dispensing records to identify patients who may have adherence problems, potentially reducing the need to assign a risk level for nonadherence. While refill histories do not perfectly coincide with actual medication use, 26 using dispensing records is a promising approach, since some pharmacies already are using dispensing records to target patients who are late refilling medications for intervention.
Pharmacists and student pharmacists frequently identified patients with potential nonadherence issues for specific medications, although other studies reported higher rates of nonadherence. 17, 18 In the original article validating the AE, 57.6% of medications were at medium or high risk for nonadherence, whereas in the present study, 32.6% of medications were at medium or high risk. 17 Similarly, in the original DRAW pilot, 90.9% of patients reported at least 1 yes response to a reason for nonadherence, and 77.3% of cases contained at least 18 whereas in the present study, 82.7% and 58.2% of patients reported 1 and 2 yes answers, respectively. Possible reasons for this variation are differences in patient characteristics, provider characteristics, medications involved, mode of delivery, and number of medications assessed at a time.
Like other studies of pharmacist interventions, time and workflow were the most common barriers cited. The DRAW had more items and thus had more time-related comments than the AE. Tool administrators also observed that the tools may be too long from the patient perspective, especially when assessing multiple medications. Assessing fewer medications during a single encounter, leveraging technology for data collection, and devising strategies for targeting (e.g., prescription claims, dispensing records) may be useful approaches given these constraints. Also, asking about medication classes/groups, such as diabetes medications or blood pressure medications, could be a way to explore variation in adherence beliefs without asking about each medication independently. Respondents commented that the paper tools were difficult to incorporate into workflow. Despite these barriers, 4 of the 11 pharmacists exposed to both tools planned to either incorporate some of the questions in their adherence communication strategy or occasionally use the tools, although with modification.
Several respondents voiced concern over the quality of some of their interactions with patients based on patient reluctance to admit nonadherence and patient defensiveness, phenomena
Code
Frequencies a Representative Quote Systematic 37 "It reminded me to ask about things I otherwise probably wouldn't ask about." Clinic student re: DRAW Recommendations 12 "This tool definitely identifies patients that are having adherence issues and provides solutions to solve different adherence issues. I liked that the tool provided guided responses to the different questions for the patient and gave lots of talking points." Community resident re: DRAW Facilitate discussion 9 "You get more insight to the patient's medication-taking experience from asking additional questions like these 2 tools rather than just asking, 'Do you remember to take your meds every day?' It was interesting to see the varying levels of adherence from med to med in the same person and also enlightening to discover different factors that contribute to nonadherence." Clinic pharmacist re: both tools a Frequencies represent the total number of quote segments associated with the given code. Quote segments could be assigned more than 1 code. DRAW = Drug Adherence Work-up. 
33
"I can see us using the Adherence Estimator due to the fact that it took less time, but honestly because the tools were not fully incorporated into our workflow, we will probably not continue to use the tools at our pharmacy." Community resident re: both tools Repetition and wording
17
"Does not feel natural within the typical dialogue of clinical care." Clinic pharmacist re: AE "Most patients were tired of answering the same questions for 4 drugs." Clinic pharmacist re: DRAW Patient not receptive
12
"I had patients become impatient and not want to finish. I had 1 patient say that she felt like I was accusing her of diverting her medications." Clinic pharmacist re: AE Prefacing 10 "After completing med reconciliation during the visit, I would ask the patient if they were willing to answer several more questions regarding a couple of their medications as part of a study looking at how patients take their medications. I did not explicitly state I was asking them/assessing their adherence with medications." Clinic pharmacist re: AE Patient confusion 10 "Some of them could not read or write. In finding this, it allowed me to tailor my presentation to them." Clinic student re: AE All meds together 10 "I didn't like naming the drugs at the top. I hardly ever had anything that was drug specific." Community student re: DRAW "After asking the questions for one medication, patients would report that the answers are the same for all of their medications. It appeared difficult for patients to think of each medication separately." Clinic student re: DRAW Patient social desirability 7 "They may have these worries, are not willing to admit it to the pharmacist." Community student re: AE "I feel like when I was talking to patients, they were telling me what I wanted to hear." Community student re: DRAW Facilitator: refill history 7 "I think it would be better only to use the tool with patients who we already think have an adherence problem." Community pharmacist re: AE Facilitator: open discussion 6 "It was just easier to make it a discussion and fill in information when necessary." Community student re: DRAW 
Theme: Translating Tools into Practice
More effort is needed to design setting-specific interventions that are compatible with workflow, patient preferences, and pharmacist preferences. This need is particularly relevant as pharmacies increase their efforts to improve adherence rates, given incentives such as Medicare star ratings and other quality measures.
Limitations
This study has several limitations. The study was designed to describe how these tools can be used in practice, not to report changes in medication adherence. Future studies are needed to investigate whether and how such adherence tools can improve the quality of adherence interventions and improve clinical outcomes. Pharmacists and student pharmacists used the tools in innovative primary care and independent community pharmacy settings, which may limit generalizability. Pharmacists in other settings or with other patient groups may have different experiences with the tools. Verification of training completion was not assessed for those administering the adherence tools. Social desirability bias of survey respondents was not likely an issue, since surveys were anonymous, and participants specifically were asked for positive and negative feedback about their experiences and how to improve the tools.
■■ Conclusions
The present study found pharmacists and student pharmacists in community pharmacy and clinic settings were successful in uncovering patient attitudes and experiences about medicines that studies have demonstrated are associated with medication nonadherence. Such interactions generally required 5 to 10 minutes and involved the administration of the tools and discussion of any issues or concerns. These tools can be incorporated into busy workflows as patient self-administered surveys and/or as discussion guides, although time limitation was a barrier to using these tools with patients. More research is needed to improve the usability of such adherence tools in practice and to test the ability of such tools to bring about improvement in medication adherence. also described in other studies. 27, 28 A possible cause may be the closed-ended phrasing of both tools when used during a discussion about nonadherence. Supporting this contention, several tool administrators modified their delivery of these tools to adopt a more open-ended communication style. When the tool is administered during the patient-provider interaction, as appeared to be the most frequent case in the present study, the vocalization of these closed-ended screening questions by the provider may set a tone less conducive to patient disclosure about medication beliefs and experiences. [29] [30] [31] While both tools have an expectation that a provider will probe the closed responses to better understand the patient's perspective, rephrasing the questions to be open may improve the quality of information the patient discloses when the provider is administering the tool and simultaneously providing feedback. It could be beneficial to separate tool administration from the patient-provider discussion, using technical staff or technology, so the provider is not associated with the line of closed-ended questioning involved with these screening tools. Also, training on techniques such as motivational interviewing may be useful, particularly using a nonjudgmental tone, open-ended questioning, and reflective listening. 32 An area for future research is examining the role of closed-and open-ended questioning in identifying and managing nonadherence using adherence tools.
Another question arising from this study is which nonadherence questions contribute to the most productive intervention. The 2 items that resonated most frequently with patients were the DRAW items addressing forgetfulness and the concern of taking too many medicines-2 areas not covered by the AE. Forgetfulness may sometimes be a manifestation of latent negative beliefs about medicines. 33, 34 While the AE items have been shown to be an efficient predictor of nonadherence, 17 these 2 DRAW items may promote dialogue in an interview format. Whether the same items that predict nonadherence also contribute to the most effective provider-patient encounter is not clear.
A specific concern for the AE was the ability of patients with low health literacy or with cognitive impairment to respond to the scaling. Alternate approaches may be needed under such conditions. Also, some tool administrators preferred to ask about all medications together, instead of individually, which was recommended in the training. This practice was contrary to research showing patients can simultaneously be adherent to one medication and nonadherent to another. 35 This difference highlighted the importance of balancing patient and provider burden and evidence-based strategies. Future research could investigate the prevalence of provider preferences and practices that may not be consistent with the adherence literature to identify topics for educational interventions. When administering the tools, some respondents reported prefacing the tool use by stating they were trying something new, or they were participating in a study. These statements may have been an effort by the tool administrator to distance her or himself from the tool, suggesting potential discomfort with the process.
